Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Mid-Cap · Crm Mutual

Crm Small/mid Cap Value Fund Investor (CRMAX)

Ticker CRMAX · · Holdings as of Jul 31, 2026

Expense ratio
1.22%$122/yr per $10k
5-yr return
+8.3%annualized
1-yr return
+3.9%as of Dec 2025
Net assets
$181.2Mall share classes
Holdings
45

Bottom line

Is CRMAX a good fund? The bottom line

CRMAX is the Investor share class of Crm Small/mid Cap Value Fund, a managed mid-cap mutual fund from Crm Mutual.

Its expense ratio is 1.22% — about $122 a year on every $10,000 invested, more expensive than 79% of mid-cap funds we track.

It returned +3.9% over one year, +8.3% a year over five years, +10.1% a year over ten (as of Dec 31, 2025, per its prospectus).

With $181 million in net assets and 45 holdings, its largest position is Bio-techne Corp (4.0%) and the top 10 make up 33.9% of the portfolio.

What to watch

  • Expensive for its category (1.22%)

Updated Nov 19, 2026

What CRMAX invests in

CRM Small/Mid Cap Value Fund seeks long-term capital appreciation.

The Fund, under normal circumstances, invests at least 80% of its assets in equity and equity related securities of U.S. and non-U.S. companies with market capitalizations at the time of initial purchase within the range of those in the Russell 2500 Value Total Return Index or in the S&P MidCap 400 Value Total Return Index (together, small/mid cap companies) that are publicly traded on a U.S. securities market. The market capitalization ranges of the Indices change constantly. The capitalization ranges of small/mid cap companies in which the Fund will invest will change in line with the index market capitalization ranges on a quarterly basis. As of December 31, 2025, the market capitalization range of the Russell 2500 Value Total Return Index was approximately $5.61million to $37.12 billion, and the market capitalization range of the S&P MidCap 400 Value Total Return Index was…

From the fund's prospectus (filed Feb 27, 2026).

CRMAX performance

Average annual total returns
1 yr5 yr10 yr
CRMAX+3.9%+8.3%+10.1%
Mid-Cap median+7.9%+8.1%+9.9%

Source: Fund prospectus, as of Dec 31, 2025

Full CRMAX performance history →

What CRMAX costs

On a $10,000 investment, CRMAX's 1.22% expense ratio costs about $122 a year. The prospectus estimates $1,477 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.

See the full CRMAX fee table →

CRMAX top 10 holdings

#Holding% of fund
1Bio-techne Corp4.00%
2Stit Govt And Agency Inst3.88%
3Bankunited Inc3.87%
4Champion Homes Inc3.79%
5Regal Rexnord Corp3.46%
6Sun Communities Inc3.21%
7Camden Property Trust2.98%
8Gates Industrial Corporation Ltd2.96%
9Vail Resorts Inc2.93%
10Steven Madden Ltd2.87%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 33.9% of the fund. See all top 25 holdings and asset mix →

Alternatives to CRMAX

More funds like CRMAX →

CRMAX FAQ

What is the expense ratio of CRMAX?
CRMAX's expense ratio is 1.22%, which works out to about $122 a year for every $10,000 invested. The prospectus estimates total costs of $1,477 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is CRMAX a good investment?
It depends on your goals, but the data points to: expensive for its category (1.22%). This is general information, not personalized advice.
What does CRMAX hold?
CRMAX's largest holdings are Bio-techne Corp (4.0%), Stit Govt And Agency Inst (3.9%), Bankunited Inc (3.9%), Champion Homes Inc (3.8%), Regal Rexnord Corp (3.5%). It holds 45 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is CRMAX's 5-year return?
CRMAX returned +8.3% a year over the five years ending Dec 31, 2025, and +10.1% a year over ten years. Past performance does not guarantee future results.
Who manages CRMAX?
CRMAX is offered by Crm Mutual through CRM Mutual Fund Trust.